Insiders · Profile

Griffin Stephen D.

President and CEO at Anika Therapeutics. Filing since 30 Apr 2026. CIK 0001831125

Company
Date
Role
Action
Shares
Amount
Of holding
30 Apr 2026
President and CEO
Bought
12,200
$149.88K
50.9%
1 decision on file.